Lyra Therapeutics, Inc. (LYRA) Financials

$10.68

$0.4 (3.89%)
Last update: 04:00 PM EST
Day's range
$9.81
Day's range
$11.04
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80M-$100M-$100MEarning201820182019201920202020202120212022202220232023202420240%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%-25000%-25000%-30000%-30000%Profit Margin
Profit Margin
Revenue
Earnings

LYRA Income statement / Annual

Last year (2024), Lyra Therapeutics, Inc.'s total revenue was $1.53 M, a decrease of 1.54% from the previous year. In 2024, Lyra Therapeutics, Inc.'s net income was -$93.44 M. See Lyra Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $1.53 M $1.56 M $1.36 M $285.00 K $0.00 $0.00 $1.24 M
Cost of Revenue $0.00 $0.00 $1.07 M $1.00 M $95.00 K $27.00 K $0.00
Gross Profit $1.06 M $1.56 M $296.00 K -$716.00 K -$95.00 K -$27.00 K $1.24 M
Gross Profit Ratio 0.69 1 0.22 -2.51 0 0 1
Research and Development Expenses $43.77 M $48.03 M $38.80 M $29.69 M $12.52 M $12.03 M $4.98 M
General & Administrative Expenses $18.50 M $19.06 M $17.56 M $14.21 M $9.69 M $4.49 M $3.53 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $18.50 M $19.06 M $17.56 M $14.21 M $9.69 M $4.49 M $3.53 M
Other Expenses $35.62 M $0.00 $1.32 M $0.00 $0.00 $0.00 $1.19 M
Operating Expenses $97.88 M $68.68 M $56.35 M $43.90 M $22.21 M $16.52 M $8.50 M
Cost And Expenses $97.88 M $68.68 M $56.35 M $43.90 M $22.21 M $16.52 M $8.50 M
Interest Income $2.95 M $4.50 M $1.04 M $102.00 K $82.00 K $213.00 K $0.00
Interest Expense $0.00 $0.00 $524.00 K $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $471.00 K $278.00 K $1.07 M $1.00 M $95.00 K $27.00 K $82.00 K
EBITDA -$60.26 M -$65.25 M -$53.92 M -$42.61 M -$22.11 M -$16.49 M -$7.18 M
EBITDA Ratio -39.28 -41.88 -39.56 -149.52 0 0 -5.77
Operating Income Ratio -62.81 -43.08 -41.31 -153.04 0 0 -5.84
Total Other Income/Expenses Net $2.95 M $4.50 M $1.04 M $102.00 K $82.00 K $213.00 K $1.23 M
Income Before Tax -$93.40 M -$62.62 M -$55.27 M -$43.51 M -$22.13 M -$16.31 M -$6.03 M
Income Before Tax Ratio -60.88 -40.19 -40.55 -152.68 0 0 -4.85
Income Tax Expense $39.00 K $59.00 K $13.00 K -$1.10 M -$82.00 K -$213.00 K -$1.23 M
Net Income -$93.44 M -$62.68 M -$55.28 M -$42.41 M -$22.05 M -$16.09 M -$6.03 M
Net Income Ratio -60.91 -40.23 -40.56 -148.81 0 0 -4.85
EPS -71.5 -63 -91.5 -163.5 -128.5 -62.5 -48
EPS Diluted -71.5 -63 -91.5 -163.5 -128.5 -62.5 -48
Weighted Average Shares Out $1.30 M $996.08 K $604.72 K $259.72 K $171.80 K $258.50 K $125.32 K
Weighted Average Shares Out Diluted $1.30 M $996.08 K $604.72 K $259.72 K $171.80 K $258.50 K $125.32 K
Link